542803 — Vaxfab Enterprises Income Statement
0.000.00%
- IN₹82.32m
- IN₹82.29m
- IN₹91.44m
Annual income statement for Vaxfab Enterprises, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.03 | 11.4 | 2.73 | 168 | 91.4 |
Cost of Revenue | |||||
Gross Profit | 0.033 | 3.38 | 1.09 | 8.58 | 11.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.74 | 12.2 | 3.7 | 163 | 135 |
Operating Profit | -0.718 | -0.784 | -0.97 | 4.51 | -43.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.119 | -0.123 | 0.033 | 5.05 | -41.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.122 | -0.123 | 0.024 | 3.9 | -35.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.122 | -0.123 | 0.024 | 3.9 | -35.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.122 | -0.123 | 0.024 | 3.9 | -35.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.05 | -0.051 | 0.01 | 1.98 | -0.916 |